Domark International (DOMK) 10-Q 20 Jan 15 2015 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Nov. 30, 2014
Document And Entity Information
Entity Registrant Name	Domark International Inc.
Entity Central Index Key	1365160
Document Type	10-Q
Document Period End Date	30-Nov-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-26
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding	5,624,995,392
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2015

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Nov. 30, 2014	31-May-14
CURRENT ASSETS
Cash and cash equivalents		$460
Loan receivable from consultant	36,203	36,203
Prepaid expenses	4,500	4,500
TOTAL CURRENT ASSETS	40,703	41,163
INVESTMENTS	1,144,166	1,144,166
OTHER ASSETS
Patents, net of accumulated amortization of $8,605 and $3,605, respectively	61,897	66,897
Licenses, net of accumulated amortization of $162,618 and $60,898 respectively	147,382	249,102
TOTAL OTHER ASSETS	209,279	315,999
TOTAL ASSETS	1,394,148	1,501,328
CURRENT LIABILITIES
Bank overdraft	18
Note payable to bank	180,000	180,000
Accounts payable and accrued expenses	61,765	56,940
Amounts due under Licensing Agreement with Wazzamba SA	224,924	224,925
Loans payable to consultants and stockholders	181,328	188,972
Convertible notes payable (net of unamortized discounts of $526,993 and $674,886 respectively)	140,044	67,414
Derivative liability for convertible notes payable	2,416,159	1,748,982
TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES	3,204,238	2,467,233
STOCKHOLDERS' DEFICIT
Preferred stock, $0.001 par value, authorized 10,000,000 shares: Series A convertible preferred stock - issued and outstanding 50,000 shares as of November 30, 2014 & May 31, 2014	50	50
Convertible preferred stock series B, $0.0001 par value, Authorized: 10,000,000
Common stock, $0.001 par value, authorized 7,500,000,000 shares: 5,749,811,000 and 801,627,000 shares issued, and 5,749,811,000 and 801,627,000 shares outstanding, as of November 30, 2014 & May 31, 2014	5,749,811	801,627
Less: Treasury stock (124,819,802 shares) as of November 30, 2014 and May 30, 2014	-124,820	-124,820
Common stock payable	858,000	858,000
Additional paid-in capital	39,176,795	43,529,923
Accumulated other comprehensive income (loss)	-112,240	-88,551
Accumulated deficit	-47,357,686	-45,942,134
TOTAL STOCKHOLDERS' DEFICIT	-1,810,090	-965,905
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$1,394,148	$1,501,328

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Nov. 30, 2014	31-May-14
Consolidated Balance Sheets Parenthetical
Patents, net of accumulated amortization	$8,605	$3,605
License, net of accumulated amortization	162,618	60,898
Convertible notes payable net of unamortized discounts	$526,993	$674,886
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock series A, par value	$0.00	$0.00
Preferred stock series A, shares authorized	10,000,000	10,000,000
Preferred stock series A, shares issued	50,000	50,000
Preferred stock series A, shares outstanding	50,000	50,000
Convertible preferred stock series B, par value	0.0001	0.0001
Convertible preferred stock series B, shares authorized	10,000,000	10,000,000
Common Stock, par value	$0.00	$0.00
Common Stock, shares authorized	7,500,000,000	7,500,000,000
Common Stock, shares issued	5,749,811,000	801,627,000
Common Stock, shares outstanding	5,749,811,000	801,627,000
Treasury Stock, Shares	124,819,802	124,819,802

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013	Nov. 30, 2014	Nov. 30, 2013
Consolidated Statements Of Operations
Sales
Cost of sales
Gross profit
Operating expenses:
General and administrative	32,163	259,559	241,806	519,002
Stock-based compensation - consultants	0	59,850	55,620	513,675
Stock-based compensation - Salaries and wages	0	55,350
Depreciation and amortization expense	53,360	360	106,720	720
Total operating expenses	85,523	319,769	404,146	1,033,397
Loss from operations	-85,523	-319,769	-427,835	-1,033,397
Other income (expense):
Other income
Revaluation of derivative liability for convertible notes	-474,291	-176,720	-667,181	-161,744
Interest expense	-196,797	-23,045	-344,230	-88,003
Total other income (expense)	-671,088	-199,765	-1,011,411	-249,747
Net loss	-756,611	-519,534	-1,415,557	-1,283,144
Statement of Comprehensive Income: Net Loss	-756,611	-519,534	-1,415,557	-1,283,144
Other Comprehensive Loss
Foreign Currency Adjustment	-12,039	0	-23,689	0
Total Other Comprehensive Loss	-12,039	0	-23,689	0
Total Comprehensive loss	($768,650)	($519,534)	($1,439,246)	($1,283,144)
Net loss per common share, basic and diluted	$0	($0.01)	$0	($0.02)
Weighted average common shares outstanding	2,855,059,171	87,316,592	2,625,689,405	75,919,384

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	($1,415,557)	($1,283,144)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	106,720	720
Common stock issued for compensation - consultants	55,620	513,675
Common stock issued as compensation		453,825
Non cash interest expense	344,230	88,003
Loss (gain) on derivative valuation	667,181	161,744
Changes in Operating assets and liabilities:
Prepaid expenses		1
Accounts payable and accrued expenses	-4,823	32,303
Accounts payable -related party	7,644
Net cash used in operating activities	-238,985	-486,698
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for investments		-134,149
Cash paid for loan receivable from consultant		-36,203
Net cash used in investing activities		-170,352
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from convertible notes payable	138,829	442,500
Proceeds from loans payable to consultants and stockholders	123,367	224,499
Payments made on loans payable to consultants and stockholders		-10,007
Net cash provided by financing activities	262,196	656,992
Total Comprehensive Loss - effects of exchange rate changes on cash	-23,689
Net increase(decrease) in cash and cash equivalents	-478	-58
CASH BALANCE BEGINNING OF PERIOD	460	20
CASH BALANCE/(BANK OVERDRAFT) END OF PERIOD	-18	-38
Cash paid for interest	20,424
Cash paid for taxes
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Shares issued for settlement of loans payable to consultants and stockholders	55,623	52,500
Shares issued for settlement of convertible notes payable	391,584	272,362
Shares issued for patent acquisition		35,500
Shares issued for equity interest in Imagic Ltd		$697,500

Description_of_Business

Description of Business	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 1 - Description of Business	DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. During 2008 and 2009, the Company acquired several operating businesses. On May 21, 2009, the Company entered into an acquisition agreement (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as "Victory Lane" (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement.
	On March 5, 2012, the Company entered into an Asset Purchase Agreement with its then controlling shareholder, R. Thomas Kidd, for the sale of the Company’s subsidiary Armada Armada/The Golf Championships and certain assets related thereto. The Company relied upon Accounting Standards Codification (“ASC”) Topic Nos, 8602025 and 8602040 to record the sale. The fair value of the transaction was measured at the fair value of the assets less any liabilities sold.
	On February 29, 2012, the Company formed a new wholly owned subsidiary, Solarwerks, Inc. in the state of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics. Solarwerks' current focus is to develop and distribute the SolaPad, a combined cover and charging system for Apple's iPad; and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone. Solarwerks competes in a market that also includes 3D Systems (DDD), Dell (DELL) and Hewlett Packard (HPQ). Solarwerks, Inc. is currently in default with the Nevada Secretary of State.
	On June 20, 2012, the Company formed a new whollyowned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system of Barefoot Science. MuscleFoot Inc. is currently in default with the Nevada Secretary of State.
	On July 20, 2012, the Company formed a new whollyowned subsidiary, DoMark Canada Inc. in the province of Ontario for the purpose of supporting the Company’s corporate operations based in Toronto, Ontario, Canada.
	On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. (“Zaktek”). Zaktek’s main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones, including the Apple iPhone® and Samsung Galaxy products to improve functionality including video and gaming abilities.
	On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark.
	On June 11, 2013, the Company then purchased 100% of South Hill Ltd., an English private limited company, which owns approximately 19% of Zaktek.

Going_Concern

Going Concern	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 2 - Going Concern	The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern. Furthermore, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors, promissory notes from lenders, and the support of certain stockholders.
	These factors raise substantial doubt about the ability of the Company to continue as a going concern. These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. In this regard, management is planning to raise any necessary additional funds through loans and additional sales of its common stock. There is no assurance that the Company will be successful in raising additional capital.

Basis_of_Presentation

Basis of Presentation	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 3 - Basis of Presentation	The unaudited consolidated financial statements as of November 30, 2014 and for the six months ended November 30, 2013 have been prepared in accordance with accounting principles generally accepted in the United States for interim consolidated financial information and with instructions to Form 10Q. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the consolidated financial position as of August 31, 2014 and the results of operations and cash flows for the three months ended August 31, 2014 and 2013. The financial data and other information disclosed in these notes to the interim consolidated financial statements related to these periods are unaudited. The results for the six month period November 30, 2014 are not necessarily indicative of the results to be expected for any subsequent quarter of the entire year ending May 31, 2015. The consolidated balance sheet at November 30, 2014 has been derived from the audited consolidated financial statements at that date.
	Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted pursuant to the Securities and Exchange Commission’s rules and regulations. These unaudited consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended May 31, 2014 as included in our annual report on Form 10K.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 4 - Summary of Significant Accounting Policies	RECENT ACCOUNTNG PRONOUNCEMENTS
	In June 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 201410, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation” (“ASU 201410”). ASU 201410 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inceptiontodate information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 201410, the Company has elected early application of this standard for the accompanying consolidated financial statements for the Quarter ended November 30, 2014 and year ended May 31, 2014. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.
	PRINCIPLES OF CONSOLIDATION
	The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, Domark Canada, Inc., Solarwerks, Inc., MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 81010153.
	Foreign Currency Translation and Transaction Gains and Losses
	We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders’ deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of income related to the recurring measurement and settlement of such transactions. The translation rates as of November 30, 2014 were $1.00 US to $.875 Canadian.
	USE OF ESTIMATES
	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.
	The primary management estimates included in these condensed consolidated financial statements are the fair value of Company stock tendered in various nonmonetary transactions and the fair value of the derivative liability for convertible notes payable.
	CASH AND CASH EQUIVALENTS
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At November 30, 2014 there weren’t any cash or cash equivalents. At May 31, 2014, cash and cash equivalents consisted only of cash in the bank.
	LOANS RECEIVABLE CONSULTANT
	The loan receivable consultants are a short term, less than one year note, due July 15, 2015, noninterest bearing
	NET LOSS PER COMMON SHARE
	Basic net loss per common share is computed by dilutive net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an antidilutive effect on diluted net loss per common share are excluded from the calculation.
	For the six months ending November 30, 2014 and 2013, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was antidilutive:
		Common Shares Equivalent
		Six Months Ended November 30,
		2014		2013
	Convertible notes payable		307,459,536		2,163,265
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		850,000
	Total common shares equivalent		358,309,536		53,013,265
	INTANGIBLE ASSETS
	Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.
	IMPAIRMENT OF LONGLIVED ASSETS
	In accordance with ASC Topic No. 3601040, longlived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
	STOCKBASED COMPENSATION
	The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation Stock Compensation, which requires all sharebased payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 71810309, Measurement Objective Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the BlackScholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.
	ASC Topic No. 505, "CompensationStock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to nonemployees for goods or services. Under this method, stock compensation expense includes compensation expense for all stockbased compensation awards granted on or after January 1, 2006, based on the grantdate fair value estimated in accordance with the provisions of ASC 505.
	RESEARCH AND DEVELOPMENT
	All research and development expenditures are expensed as incurred.
	REVENUE RECOGNITION
	The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

Investments

Investments	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 5 - Investments	Investments consist of:
			November 30,		May 31,
			2014		2014
	Imagic Ltd. 40% equity interest		$	1,094,166	$	1,094,166
	Barefoot Science Products & Services Inc. 15% equity interest			50,000		50,000
	Total		$	1,144,166	$	1,144,166
	The cost of the 40% equity interest in Imagic Ltd. at November 30, 2014 consists of:
	July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.	$	697,500
	December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.			96,005
	Cash payments to or for the benefit of Imagic Ltd.			150,661
	Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings			150,000
	Total	$		1,094,166
	Imagic is a privately owned company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products. Imagic shares are not quoted or traded on any securities exchange or in any recognized overthe counter market. Imagic is accounted for on the equity method of accounting. The Company consolidates entities that we control. The Company accounts for investments in joint ventures using the equity method of accounting when we exercise significant influence over the venture. If the Company does not exercise significant influence, we account for the investment using the cost method of accounting. Imagic did not have any revenues or expenses for the period ended November 30, 2014.

Licensing_Agreement_With_Wazza

Licensing Agreement With Wazzamba Sa	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 6 - Licensing Agreement With Wazzamba Sa	During the three months ended February 28, 2014, the Company executed a Licensing Agreement with Wazzamba SA (the “Licensor”). The agreement provides the Company an exclusive license to use certain technology (which permits thirdparty subscribers to integrate a fully equipped online shop into their websites) in Canada and the United States for an initial term ending July 31, 2015. The agreement provides for the Company to pay the Licensor “Flat Fee” compensation of $ 300,000 in 3 installments of $100,000 each (first installment payable within 5 days of the signing of the agreement, second installment payable on July 1, 2014, and third installment payable on February 1, 2015) plus “Revenue Share” compensation equal to 50% of Net Commissions generated by the Company payable monthly. In the event that the Company does not generate $500,000 in Net Commissions by January 31, 2015, the Licensor has the right to cancel the agreement with one month notice (in which case the third $100,000 installment will no longer be due). With respect to an Extended License Term after July 31, 2015, the agreement provides the Company a right of first refusal to match any offer received by the Licensor from a third party.
	At November 30, 2014, the Company has a recorded intangible asset for “Licensing Agreement with Wazzamba SA” in the amount of $300,000, and included the liability under the Licenses net of accumulated amortization. Commencing March 1, 2014, the Company will amortize the $300,000 intangible asset on a straight line basis over the remaining 17 months of the Initial Term ending July 31, 2015 (approximately $17,647 per month).
	On March 27, 2014, the Company paid $25,000 of the first $100,000 “Flat Fee” installment due the Licensor under the agreement. The other $75,000 due is presently past due.
	Licenses, net of accumulated amortization are as follows:
		November 30,			May 31,
		2014			2014
	Wazzamba, S.A .	$	300,000		$	300,000
	Bioharmonics		10,000			10,000
	Subtotal		310,000			310,000
	Accumulated amortization		(162,618	)		(60,898	)
	Total	$	147,382		$	249,102

Note_Payable_To_Bank

Note Payable To Bank	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 7 - Note Payable To Bank	In December 2013, the Company entered into a Loan Agreement with a bank located in Maryland. The related Promissory Note in the amount of $180,000 bears interest at a rate at 10% payable monthly, and is due in full on December 31, 2014, and is secured by a 25,000,000 shares of Domark International, Inc (Common Stock Reserve as defined in the Loan Agreement), a Guaranty of Payment from the Company’s chief financial officer and his wife, and certain real property owned by the Company’s chief financial officer and his wife.

Loans_Payable_to_Consultants_a

Loans Payable to Consultants and Stockholders	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 8 - Loans Payable to Consultants and Stockholders	Loans payable to consultants and stockholders consist of:
		November 30,		May 31,
		2014		2014
	Consultant and stockholder	$	80,796	$	90,402
	President of DoMark		45,850		47,500
	Non Exec Chairman of Domark				11,875
	Chairman of Barefoot Science and affiliate		21,500		21,500
	Consultant		16,097		16,097
	Consultant		17,085		1,598
	Total	$	181,328	$	188,972
	The loans are informal and do not provide for interest or a stated maturity date.

Convertible_Notes_Payable

Convertible Notes Payable	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 9 - Convertible Notes Payable	At November 30, 2014, the convertible notes payable consisted of;
											Unamortized		Net Carrying
	Date of Note		Noteholder	Interest Rate			Maturity Date	Principal Amount			Debt Discount		Amount
	12/19/13		JMJ Financial Inc.	10		%	12/19/14		43,922	(i)		27,731		16,191
	2/26/14		LG Capital Funding, Inc.		8	%	9/26/14		9,467	(a)		9,467		0
	3/7/14		JSJ Investments, Inc		12	%	10/7/14		19,828	(g)		19,374		454
	3/28/14		Redwood Fund, III		10	%	9/28/14		38,409	(f)		38,409		0
	3/28/14		Redwood Management, LLC		10	%	9/28/14		50,000	(g)		30,191		19,809
	3/28/14		Asher Enterprises, Inc		8	%	9/28/14		12,040	(l)		12,040		0
	4/14/14		WHC Capital, Inc		12	%	10/14/14		43,000	(i)		39,138		3,862
	4/11/14		Tonaquint Inc		12	%	10/11/14		48,246	(g)		28,296		19,950
	4/24/14		JSJ Investments, Inc				10/24/14		50,000	(g)		30,191		19,809
	5/12/14		Iconic Holdings, LLC.		10	%	11/12/14		49,793	(g)		39,222		10,571
	5/14/14		KGM Worldwide, Inc		8	%	11/14/14		32,500	(l)		22,450		10,050
	6/12/14		Adar Bays, LLC.		8	%	12/12/15		52,500	(g)		40,765		11,735
	6/23/14		JMJ Financial, Inc.		10	%	12/23/14		50,000	(i)		38,568		11,432
	7/3/14		LG Capital, Inc		8	%	1/3/15		36,750	(a)		27,789		8,961
	7/22/14		Redwood Fund, III		10	%	1/22/15		100,082	(g)		93,257		6,825
	8/14/14		KBM Worldwide, Inc		8	%	2/14/15		27,500	(i)		27,156		344
	10/8//14		LG Capital Funding, Inc.		8	%	4/8/15		3,000	(a)		2,949		51
	Totals							$	667,037		$	526,993	$	140,044
	Legend
	(a)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.
	(b)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion.
	(c)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.08 or 50% of the lowest closing price during the 10 trading days prior to the notice of conversion.
	(d)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.0725 or 34% of the lowest closing price during the 20 trading days prior to the notice of conversion.
	(e)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 55% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
	(f)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion.
	(g)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.
	(h)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
	(i)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion.
	(j)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 20 trading days prior to the notice of conversion.
	(k)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
	(l)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

Stockholders_Equity

Stockholders Equity	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 10 - Stockholders Equity	Series A Convertible Preferred Stock
	Each share of Series A Convertible Preferred Stock has 1,000 voting rights and is convertible into 1,000 shares of common stock.
	Common Stock Issuances
	On September 4, 2014, the Company issued 70,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $14,040 principal amount of convertible notes payable.
	On September 4, 2014, the Company issued 170,760,000 shares of common stock for Iconic Holdings, LLC in satisfaction of $8,538 of principal amount of convertible notes payable.
	On September 12, 2014, the Company issued 78,759,945 shares of common stock for LG Capital, Inc. in satisfaction of $3,938 of principal amount of convertible notes payable.
	On September 19, 2014, the Company issued 170,760,000 shares of common stock for Iconic Holdings, LLC in satisfaction of $8,538 of principal amount of convertible notes payable
	On September 19, 2014, the Company issued 93,841,481 shares of common stock for JSJ Investments, Inc. in satisfaction of $4,692 of principal amount of convertible notes payable.
	On September 19, 2014, the Company issued 100,271,400 shares of common stock for LG Capital, Inc. in satisfaction of $5,014 of principal amount of convertible notes payable.
	On September 19, 2014, the Company issued 100,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $12,000 of principal amount of convertible notes payable.
	On September 23, 2014, the Company issued 98,439,714 shares of common stock for JSJ Investments, Inc. in satisfaction of $4,922 of principal amount of convertible notes payable.
	On October 1, 2014, the Company issued 103,263,260 shares of common stock for JSJ Investments, Inc. in satisfaction of $2,582 of principal amount of convertible notes payable.
	On October 1, 2014, the Company issued 265,320,000 shares of common stock for Iconic Holdings, LLC. in satisfaction of $6,633 of principal amount of convertible notes payable.
	On October 1, 2014, the Company issued 105,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $6,300 of principal amount of convertible notes payable.
	On October 1, 2014, the Company issued 133,984,700 shares of common stock for Redwood Fund, III in satisfaction of $2,680 of principal amount of convertible notes payable.
	On October 1, 2014, the Company issued 141,004,800 shares of common stock to Redwood Fund III, Inc. in satisfaction of $2,680 of principal amount of convertible notes payable.
	On October 16, 2014, the Company issued 64,500,000 shares of common stock to KBM Worldwide, Inc., Inc. in satisfaction of $3,225 principal amount of convertible notes payable.
	On October 16, 2014, the Company issued 87,800,000 shares of common stock to KBM Worldwide, Inc.in satisfaction of $4,390 principal amount of convertible notes payable..
	On October 16, 2014, the Company issued 92,480,000 shares of common stock to WHC Captial, Inc. in satisfaction of $4,624 principal amount of convertible notes payable.
	On October 16, 2014, the Company issued 175,750,000 shares of common stock to Tonaquint, Inc. in satisfaction of $4,393 principal amount of convertible notes payable.
	On October 20, 2014, the Company issued 152,300,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $7,615 principal amount of convertible notes payable.
	On October 20, 2014, the Company issued 148,392,800 shares of common stock to Redwood Fund, III, Inc. in satisfaction of $2,968 principal amount of convertible notes payable.
	On October 30,, 2014, the Company issued 184,359,000 shares of common stock to LG Capital Funding, Inc. in satisfaction of $3,687 principal amount of convertible notes payable.
	On November 10, 2014, the Company issued 152,300,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $7,615 principal amount of convertible notes payable.
	On November 10, 2014 the Company issued 157,500,000 shares of common stock Tonaquint, Inc in satisfaction of $3,937 principal amount of convertible notes payable..
	On November 11, 2014, the Company issued 324,186,800 shares of common stock to Iconic Holdings, LLC. in satisfaction of $8,105 principal amount of convertible notes payable.
	On November 19, 2014, the Company issued 107,520,000 shares of common stock to WHC Capital Inc. in satisfaction of $5,376 principal amount of convertible notes payable.
	On November 19, 2014, the Company issued 156,167,800 shares of common stock to KBM Worldwide, Inc in satisfaction of $7,615 principal amount of convertible noted payable.
	On November 19, 2014,, the Company issued 222,151,000 shares of common stock to LG Capital Funding, Inc. in satisfaction of $4,443 principal amount of convertible notes payable.
	On November 20, 2014, the Company issued 212,530,662 shares of common stock to Iconic Holdings, LLC in satisfaction of $5,207 principal amount of loan payable.
	Warrants to Purchase Common Stock
	A summary of warrant activity for the six months ending November 30, 2014 and for the year ended May 31, 2014 are as follows:
		Weighted Average
		Number of				Exercise
		Warrants				Price
	Outstanding at May 31, 2012	-				$
	Granted		850,000				0.42
	Exercised
	Cancelled
	Outstanding at May 31, 2013		850,000				0.42
	Granted
	Exercised
	Cancelled
	Outstanding at November 30, 2014		850,000			$	0.42
	Warrants outstanding at November 30, 2014 consist of:
	Date Granted	Number Outstanding		Exercise price			Expiration Date
	25-May-12	100,000		$	1		25-May-15
	12-Jun-12	150,000		$	1		12-Jun-15
	26-Jun-12	100,000		$	1		26-Jun-15
	1-Jan-12	500,000		$	0.01		1-Jan-15
	Totals	850,000

Fair_Value_Measurements_and_De

Fair Value Measurements and Derivative Liabiliity	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 11 - Fair Value Measurements and Derivative Liabiliity	The Company evaluates all of it financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then revalued at each reporting ate, with changes in the fair value reported as charges or credits to income. For optionbased derivative financial instruments, the Companyuses the BlackScholes optionpricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period derivative instrument liabilities are classified in the balance sheet as current or noncurrent based on whether or not netcash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
	During the period ended November 30, 2014 the Company entered into several convertible note agreements. The conversion option and the outstanding common stock warrants on that date which were tainted by the convertible note were classified as derivative liabilities at their fair value on the date of issuance.
	Under ASC815 the conversion options embedded in the notes payable described in Note 9 require liability classification because they do not contain an explicit limit to the number of shares that could be issued upon settlement.
	As defined in FASB ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).
	The three levels of the fair value hierarchy are as follows:
	Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchangetraded derivatives, marketable securities and listed equities.
	Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date.
	Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
	Derivative liability — the Company’s derivative liability is classified within Level 3 of the fair value hierarchy.
	The Company uses the Black Scholes Option Pricing Model to value its option based derivatives based upon the following assumptions: dividend yield of 0%, volatility of stock price 0%, risk free rate varying from 8 to 12 % and an expected term equal to the remaining conversion of the note.
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as at November 30, 2014.
	Recurring Fair Value Measurements	Level 1		Level 2		Level 3		Total
	LIABILITIES:
	Derivative liability November 30, 2014		-		-		2,416,159		2,416,159
	Derivative liability May 31, 2014		-		-		1,748,982		1,748,982

Commitments_and_Contingencies

Commitments and Contingencies	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
Note 12 - Commitments and Contingencies	License Agreements
	On February 29, 2012, the Company entered into a Memorandum of Agreement with Xiamen Taiyang Neng Gongsi and Michael Franklin. For and in consideration of the payment of an initial license fee of $10,000, and for the future payment of royalties of $5.00 per SolaPad unit sold, Xiamen granted an exclusive worldwide license and joint patent rights to the Company for a solar charging case for IPAD, including IPAD 3. The license under the Agreement expires on December 31, 2018.
	On April 19, 2013, our subsidiary DoMark Canada Inc. executed an agreement with Bioharmonics Technologies Cop. (“Bioharmoniecs”). The agreement provided for the acquisition of certain inventions and related patents and patent applications in exchange for 500,000 shares of DoMark common stock (which was delivered April 19, 2013) and $30,000 cash payable no later than October 17, 2013 (which was satisfied through the delivery of an additional 500,000 shares of DoMark common stock to Bioharmonics on August 15, 2013). The agreement also provides for a royalty obligation payable quarterly to Bioharmonics equal to 10% of the wholesale price for each unit using infrared and solar charging.
	In January 2014, the Company executed a Licensing Agreement with Wazzamba SA. See Note 6.
	Employment Agreements
	On May 25, 2012, the Company entered into an employment agreement with its President, R. Brentwood Strasler, for an indefinite period or until terminated. Mr. Strasler is entitled to an annual salary of $150,000 USD and 100,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Strasler is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Strasler.
	On June 15, 2012, the Company entered into an employment agreement with its Chief Executive Officer Andrew Ritchie, for an indefinite period or until terminated. Mr. Ritchie is entitled to an annual salary of $240,000 USD and 150,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Ritchie is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Richie.
	Lease Agreement
	On August 1, 2013, the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. At November 30, 2014, the future lease commitments on this lease for the years ended May 31, are as follows, and are in U.S. dollars:
	2015	$	22,528
	2016		47,616
	2017		47,616
	2018		47,616
	Thereafter		7,936
	Total	$	173,312

Subsequent_Event

Subsequent Event	6 Months Ended
	Nov. 30, 2014
Notes to Financial Statements
NOTE 13 b Subsequent Event	In January 2015, the Company entered into a joint venture agreement with Mobil Lads, Corp, to acquire 75% of Simbadeals North American licensing rights, for $700,000 value of Mobile Lads Corp common stock and $225,000 in cash. The cash will be used by Domark to pay off the existing licensing responsibilities to Wazzamba ( the program developer of Simbadeals). Mobil Lads Corp will manage the future of Simbadeals and will be fully responsible for all future funding of the operation. Domark will retain the 25% interest in the Joint Venture.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Nov. 30, 2014
Summary Of Significant Accounting Policies Policies
Recent Accountng Pronouncements	In June 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 201410, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation” (“ASU 201410”). ASU 201410 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inceptiontodate information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 201410, the Company has elected early application of this standard for the accompanying consolidated financial statements for the Quarter ended November 30, 2014 and year ended May 31, 2014. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.
Principles of Consolidation	The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, Domark Canada, Inc., Solarwerks, Inc., MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 81010153.
Foreign Currency Translation and Transaction Gains and Losses	We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders’ deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of income related to the recurring measurement and settlement of such transactions. The translation rates as of November 30, 2014 were $1.00 US to $.875 Canadian.
Use of Estimates	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.
	The primary management estimates included in these condensed consolidated financial statements are the fair value of Company stock tendered in various nonmonetary transactions and the fair value of the derivative liability for convertible notes payable.
Cash and Cash Equivalents	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At November 30, 2014 there weren’t any cash or cash equivalents. At May 31, 2014, cash and cash equivalents consisted only of cash in the bank.
Loans Receivable Consultant	The loan receivable consultants are a short term, less than one year note, due July 15, 2015, noninterest bearing.
Net Loss Per Common Share	Basic net loss per common share is computed by dilutive net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an antidilutive effect on diluted net loss per common share are excluded from the calculation.
	For the six months ending November 30, 2014 and 2013, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was antidilutive:
		Common Shares Equivalent
		Six Months Ended November 30,
		2014		2013
	Convertible notes payable		307,459,536		2,163,265
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		850,000
	Total common shares equivalent		358,309,536		53,013,265
Intangible Assets	Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.
Impairment of Long-Lived Assets	In accordance with ASC Topic No. 3601040, longlived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Stock Based Compensation	The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation Stock Compensation, which requires all sharebased payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 71810309, Measurement Objective Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the BlackScholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.
	ASC Topic No. 505, "CompensationStock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to nonemployees for goods or services. Under this method, stock compensation expense includes compensation expense for all stockbased compensation awards granted on or after January 1, 2006, based on the grantdate fair value estimated in accordance with the provisions of ASC 505.
Research and Development	All research and development expenditures are expensed as incurred.
Revenue Recognition	The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Nov. 30, 2014
Summary Of Significant Accounting Policies Tables
Net Loss Per Common Share	For the six months ending November 30, 2014 and 2013, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was antidilutive:
		Common Shares Equivalent
		Six Months Ended November 30,
		2014		2013
	Convertible notes payable		307,459,536		2,163,265
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		850,000
	Total common shares equivalent		358,309,536		53,013,265

Investments_Tables

Investments (Tables)	6 Months Ended
	Nov. 30, 2014
Investments Tables
Investments	Investments consist of:
			November 30,		May 31,
			2014		2014
	Imagic Ltd. 40% equity interest		$	1,094,166	$	1,094,166
	Barefoot Science Products & Services Inc. 15% equity interest			50,000		50,000
	Total		$	1,144,166	$	1,144,166
Cost of equity interest	The cost of the 40% equity interest in Imagic Ltd. at November 30, 2014 consists of:
	July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.	$	697,500
	December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.			96,005
	Cash payments to or for the benefit of Imagic Ltd.			150,661
	Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings			150,000
	Total	$		1,094,166

Licensing_Agreement_With_Wazza1

Licensing Agreement With Wazzamba Sa (Tables)	6 Months Ended
	Nov. 30, 2014
Licensing Agreement With Wazzamba Sa Tables
Licenses, net of accumulated amortization	Licenses, net of accumulated amortization are as follows:
		November 30,			May 31,
		2014			2014
	Wazzamba, S.A .	$	300,000		$	300,000
	Bioharmonics		10,000			10,000
	Subtotal		310,000			310,000
	Accumulated amortization		(162,618	)		(60,898	)
	Total	$	147,382		$	249,102

Loans_Payable_to_Consultants_a1

Loans Payable to Consultants and Stockholders (Tables)	6 Months Ended
	Nov. 30, 2014
Loans Payable To Consultants And Stockholders Tables
Loans payable to consultants and stockholders	Loans payable to consultants and stockholders consist of:
		November 30,		May 31,
		2014		2014
	Consultant and stockholder	$	80,796	$	90,402
	President of DoMark		45,850		47,500
	Non Exec Chairman of Domark				11,875
	Chairman of Barefoot Science and affiliate		21,500		21,500
	Consultant		16,097		16,097
	Consultant		17,085		1,598
	Total	$	181,328	$	188,972

Convertible_Notes_Payable_Tabl

Convertible Notes Payable (Tables)	6 Months Ended
	Nov. 30, 2014
Convertible Notes Payable Tables
Convertible notes payable	At November 30, 2014, the convertible notes payable consisted of;
										Unamortized		Net Carrying
	Date of Note	Noteholder	Interest Rate			Maturity Date	Principal Amount			Debt Discount		Amount
	12/19/13	JMJ Financial Inc.	10		%	12/19/14		43,922	(i)		27,731		16,191
	2/26/14	LG Capital Funding, Inc.		8	%	9/26/14		9,467	(a)		9,467		0
	3/7/14	JSJ Investments, Inc		12	%	10/7/14		19,828	(g)		19,374		454
	3/28/14	Redwood Fund, III		10	%	9/28/14		38,409	(f)		38,409		0
	3/28/14	Redwood Management, LLC		10	%	9/28/14		50,000	(g)		30,191		19,809
	3/28/14	Asher Enterprises, Inc		8	%	9/28/14		12,040	(l)		12,040		0
	4/14/14	WHC Capital, Inc		12	%	10/14/14		43,000	(i)		39,138		3,862
	4/11/14	Tonaquint Inc		12	%	10/11/14		48,246	(g)		28,296		19,950
	4/24/14	JSJ Investments, Inc				10/24/14		50,000	(g)		30,191		19,809
	5/12/14	Iconic Holdings, LLC.		10	%	11/12/14		49,793	(g)		39,222		10,571
	5/14/14	KGM Worldwide, Inc		8	%	11/14/14		32,500	(l)		22,450		10,050
	6/12/14	Adar Bays, LLC.		8	%	12/12/15		52,500	(g)		40,765		11,735
	6/23/14	JMJ Financial, Inc.		10	%	12/23/14		50,000	(i)		38,568		11,432
	7/3/14	LG Capital, Inc		8	%	1/3/15		36,750	(a)		27,789		8,961
	7/22/14	Redwood Fund, III		10	%	1/22/15		100,082	(g)		93,257		6,825
	8/14/14	KBM Worldwide, Inc		8	%	2/14/15		27,500	(i)		27,156		344
	10/8//14	LG Capital Funding, Inc.		8	%	4/8/15		3,000	(a)		2,949		51
	Totals						$	667,037		$	526,993	$	140,044

Stockholders_Equity_Tables

Stockholders Equity (Tables)	6 Months Ended
	Nov. 30, 2014
Stockholders Equity Tables
Summary of warrant activity	A summary of warrant activity for the six months ending November 30, 2014 and for the year ended May 31, 2014 are as follows:
		Weighted Average
		Number of				Exercise
		Warrants				Price
	Outstanding at May 31, 2012	-				$
	Granted		850,000				0.42
	Exercised
	Cancelled
	Outstanding at May 31, 2013		850,000				0.42
	Granted
	Exercised
	Cancelled
	Outstanding at November 30, 2014		850,000			$	0.42
Warrants outstanding	Warrants outstanding at November 30, 2014 consist of:
	Date Granted	Number Outstanding		Exercise price			Expiration Date
	25-May-12	100,000		$	1		25-May-15
	12-Jun-12	150,000		$	1		12-Jun-15
	26-Jun-12	100,000		$	1		26-Jun-15
	1-Jan-12	500,000		$	0.01		1-Jan-15
	Totals	850,000

Fair_Value_Measurements_and_De1

Fair Value Measurements and Derivative Liabiliity (Tables)	6 Months Ended
	Nov. 30, 2014
Fair Value Measurements And Derivative Liabiliity Tables
Recurring Fair Value Measurements	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as at November 30, 2014.
	Recurring Fair Value Measurements	Level 1		Level 2		Level 3		Total
	LIABILITIES:
	Derivative liability November 30, 2014		-		-		2,416,159		2,416,159
	Derivative liability May 31, 2014		-		-		1,748,982		1,748,982

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	6 Months Ended
	Nov. 30, 2014
Commitments And Contingencies Tables
Future Lease Commitments	On August 1, 2013, the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. At November 30, 2014, the future lease commitments on this lease for the years ended May 31, are as follows, and are in U.S. dollars:
	2015	$	22,528
	2016		47,616
	2017		47,616
	2018		47,616
	Thereafter		7,936
	Total	$	173,312

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details)	6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
Summary Of Significant Accounting Policies Details
Convertible notes payable	307,459,536	2,163,265
Series A convertible preferred stock	50,000,000	50,000,000
Warrants	850,000	850,000
Total common shares equivalent	358,309,536	53,013,265

Investments_Details

Investments (Details) (USD $)	Nov. 30, 2014	31-May-14
Investments Details
Imagic Ltd. - 40% equity interest	$1,094,166	$1,094,166
Barefoot Science Products & Services Inc. - 15% equity interest	50,000	50,000
Total	$1,144,166	$1,144,166

Investments_Details_1

Investments (Details 1) (USD $)	Nov. 30, 2014	31-May-14
Investments Details
July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.	697,500
December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.	96,005
Cash payments to or for the benefit of Imagic Ltd.	$150,661
Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings	150,000
Total	$1,094,166	$1,094,166

Licensing_Agreement_With_Wazza2

Licensing Agreement With Wazzamba Sa (Details) (USD $)	Nov. 30, 2014	31-May-14
Licensing Agreement With Wazzamba Sa Details
Wazzamba, S.A.	$300,000	$300,000
Bioharmonics	10,000	10,000
Subtotal	310,000	310,000
Accumulated amortization	-162,618	-60,898
Total	$147,382	$249,102

Licensing_Agreement_With_Wazza3

Licensing Agreement With Wazzamba Sa (Details Narrative) (USD $)	Nov. 30, 2014
Licensing Agreement With Wazzamba Sa Details Narrative
Intangible asset for Licensing Agreement	$300,000

Loans_Payable_to_Consultants_a2

Loans Payable to Consultants and Stockholders (Details) (USD $)	Nov. 30, 2014	31-May-14
Loans payable to consultants and stockholders	$181,328	$188,972
Consultant And Stockholder [Member]
Loans payable to consultants and stockholders	80,796	90,402
President Of DoMark [Member]
Loans payable to consultants and stockholders	45,850	47,500
Non Exec Chairman Of Domark [Member]
Loans payable to consultants and stockholders		11,875
Chairman Of Barefoot Science And Affiliate [Member]
Loans payable to consultants and stockholders	21,500	21,500
Consultant [Member]
Loans payable to consultants and stockholders	16,097	16,097
Consultant One [Member]
Loans payable to consultants and stockholders	$17,085	$1,598

Convertible_Notes_Payable_Deta

Convertible Notes Payable (Details) (USD $)	6 Months Ended
	Nov. 30, 2014		31-May-14
Principal Amount	$667,037
Unamortized Debt Discount	526,993		674,886
Net Carrying Amount	140,044		67,414
JMJ Financial Inc. [Member]
Date of Note	19-Dec-13
Interest Rate	10.00%
Maturity date	12/19/14
Principal Amount	43,922	[1]
Unamortized Debt Discount	27,731
Net Carrying Amount	16,191
LG Capital Funding, Inc. [Member]
Date of Note	26-Feb-14
Interest Rate	8.00%
Maturity date	9/26/14
Principal Amount	9,467	[2]
Unamortized Debt Discount	9,467
Net Carrying Amount	0
JSJ Investments, Inc [Member]
Date of Note	7-Mar-14
Interest Rate	12.00%
Maturity date	10/7/14
Principal Amount	19,828	[3]
Unamortized Debt Discount	19,374
Net Carrying Amount	454
Redwood Fund, III [Member]
Date of Note	28-Mar-14
Interest Rate	10.00%
Maturity date	9/28/14
Principal Amount	38,409	[4]
Unamortized Debt Discount	38,409
Net Carrying Amount	0
Redwood Management, LLC [Member]
Date of Note	28-Mar-14
Interest Rate	10.00%
Maturity date	9/28/14
Principal Amount	50,000	[3]
Unamortized Debt Discount	30,191
Net Carrying Amount	19,809
Asher Enterprises, Inc [Member]
Date of Note	28-Mar-14
Interest Rate	8.00%
Maturity date	9/28/14
Principal Amount	12,040	[5]
Unamortized Debt Discount	12,040
Net Carrying Amount	0
WHC Capital, Inc [Member]
Date of Note	14-Apr-14
Interest Rate	12.00%
Maturity date	10/14/14
Principal Amount	43,000	[1]
Unamortized Debt Discount	39,138
Net Carrying Amount	3,862
Tonaquint Inc [Member]
Date of Note	11-Apr-14
Interest Rate	12.00%
Maturity date	10/11/14
Principal Amount	48,246	[3]
Unamortized Debt Discount	28,296
Net Carrying Amount	19,950
JSJ Investments, Inc One [Member]
Date of Note	24-Apr-14
Interest Rate	0.00%
Maturity date	10/24/14
Principal Amount	50,000	[3]
Unamortized Debt Discount	30,191
Net Carrying Amount	19,809
Iconic Holdings, LLC [Member]
Date of Note	12-May-14
Interest Rate	10.00%
Maturity date	11/12/14
Principal Amount	49,793	[3]
Unamortized Debt Discount	39,222
Net Carrying Amount	10,571
KGM Worldwide, Inc [Member]
Date of Note	14-May-14
Interest Rate	8.00%
Maturity date	11/14/14
Principal Amount	32,500	[5]
Unamortized Debt Discount	22,450
Net Carrying Amount	10,050
Adar Bays, LLC [Member]
Date of Note	12-Jun-14
Interest Rate	8.00%
Maturity date	12/12/15
Principal Amount	52,500	[3]
Unamortized Debt Discount	40,765
Net Carrying Amount	11,735
JMJ Financial, Inc One [Member]
Date of Note	23-Jun-14
Interest Rate	10.00%
Maturity date	12/23/14
Principal Amount	50,000	[1]
Unamortized Debt Discount	38,568
Net Carrying Amount	11,432
LG Capital, Inc [Member]
Date of Note	3-Jul-14
Interest Rate	8.00%
Maturity date	1/3/15
Principal Amount	36,750	[2]
Unamortized Debt Discount	27,789
Net Carrying Amount	8,961
Redwood Fund, III One [Member]
Date of Note	22-Jul-14
Interest Rate	10.00%
Maturity date	1/22/15
Principal Amount	100,082	[3]
Unamortized Debt Discount	93,257
Net Carrying Amount	6,825
KBM Worldwide, Inc [Member]
Date of Note	14-Aug-14
Interest Rate	8.00%
Maturity date	2/14/15
Principal Amount	27,500	[1]
Unamortized Debt Discount	27,156
Net Carrying Amount	344
LG Capital Funding, Inc One [Member]
Date of Note	8-Oct-14
Interest Rate	8.00%
Maturity date	4/8/15
Principal Amount	3,000	[2]
Unamortized Debt Discount	2,949
Net Carrying Amount	$51
[1]	(i) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion.
[2]	(a) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.
[3]	(g) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.
[4]	(f) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion.
[5]	(l) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

Stockholders_Deficit_Details

Stockholders' Deficit (Details) (USD $)	6 Months Ended	12 Months Ended
	Nov. 30, 2014	31-May-14
Stockholders Deficit Details
Outstanding Number of Warrants, Beginning Balance	850,000
Granted		850,000
Exercised
Cancelled
Outstanding Number of Warrants, Ending Balance	850,000	850,000
Weighted Average Exercise Price, Beginning Balance	$0.42
Granted		$0.42
Exercised
Cancelled
Weighted Average Exercise Price, Ending Balance	$0.42	$0.42

Stockholders_Deficit_Details_1

Stockholders' Deficit (Details 1) (USD $)	6 Months Ended
	Nov. 30, 2014	31-May-14	31-May-13
Number Of Warrant Outstanding	850,000	850,000
Warrant [Member]
Date Granted	25-May-12
Number Of Warrant Outstanding	100,000
Exercise price	$1
Expiration Date	25-May-15
Warrant One [Member]
Date Granted	12-Jun-12
Number Of Warrant Outstanding	150,000
Exercise price	$1
Expiration Date	12-Jun-15
Warrant Two [Member]
Date Granted	26-Jun-12
Number Of Warrant Outstanding	100,000
Exercise price	$1
Expiration Date	26-Jun-15
Warrant Three [Member]
Date Granted	1-Jan-12
Number Of Warrant Outstanding	500,000
Exercise price	$0.01
Expiration Date	1-Jan-15

Fair_Value_Measurements_and_De2

Fair Value Measurements and Derivative Liabiliity (Details) (USD $)	Nov. 30, 2014
LIABILITIES
Derivative liability- August 31, 2014	$2,416,159
Derivative liability- May 31, 2014	1,748,982
Level 1 [Member]
LIABILITIES
Derivative liability- August 31, 2014
Derivative liability- May 31, 2014
Level 2 [Member]
LIABILITIES
Derivative liability- August 31, 2014
Derivative liability- May 31, 2014
Level 3 [Member]
LIABILITIES
Derivative liability- August 31, 2014	2,416,159
Derivative liability- May 31, 2014	$1,748,982

Recovered_Sheet1

Commitments And Contingencies (Details) (USD $)	Nov. 30, 2014
Commitments And Contingencies Details
2015	$22,528
2016	47,616
2017	47,616
2018	47,616
Thereafter	7,936
Total	$173,312